Skip to main content

Advertisement

SpringerLink
Log in

Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors

  • SHORT REPORT
  • Published:
Investigational New Drugs Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Izzedine H, Ederhy S, Goldwasser F, Soria JC, Milano G, Cohen A, Khayat D, Spano JP (2009) Management of hypertension in angiogenesis inhibitor-treated patients. Ann Oncol 20:807–815

    Article  CAS  PubMed  Google Scholar 

  2. Launay-Vacher V, Deray G (2009) Hypertension and proteinuria: a class-effect of antiangiogenic therapies. Anticancer Drugs 20:81–82

    Article  CAS  PubMed  Google Scholar 

  3. Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99:1232–1239

    Article  PubMed  Google Scholar 

  4. Scappaticci FA, Fehrenbacher L, Cartwright T, Hainsworth JD, Heim W, Berlin J, Kabbinavar F, Novotny W, Sarkar S, Hurwitz H (2005) Surgical wound healing complications in metastatic colorectal cancer patients treated with bevacizumab. J Surg Oncol 91:173–180

    Article  CAS  PubMed  Google Scholar 

  5. Ferté C, Massard C, Moldovan C, Desruennes E, Loriot Y, Soria JC (2009) Wound healing delay after central veinous access following DCF/VEGF-trap therapy. Invest New Drugs Feb 17 [e-pub]

  6. Prulière-Escabasse V, Escudier E, Balheda R, Soria JC, Coste A, Massard C (2009) Rhinitis and epistaxis in patients treated by anti-angiogenic therapy. Invest New Drugs 27:285–286

    Article  PubMed  Google Scholar 

  7. Jacobson BH, Johnson A, Grywalski C, Silbergleit A, Jacobson G, Benninger MS (1997) The voice handicap index (VHI): development and validation. Am J Speech Lang Pathol 6:66–70

    Google Scholar 

  8. Woisard V, Bodin S, Puech M (2004) The “Voice Handicap Index”: impact of the French translation on validity. Rev Laryngol Otol Rhinol (Bord) 125:307–312

    CAS  Google Scholar 

  9. Boersma P, Weenink D (2005) Praat: doing phonetics by computer (version 4.3.04) [computer program] Retrieved March 8, 2005 from http://www.praat.org/

Download references

Author information

Authors and Affiliations

  1. Department of Otolaryngology Head & Neck Surgery, Institut Gustave Roussy, Paris, France

    Dana M. Hartl

  2. Department of Medicine, Phase I Unit (SITEP), Institut Gustave Roussy, Paris, France

    Charles Ferté, Yohann Loriot, Carlos Gomez Roca, Rastislav Bahleda, Cristian Moldovan, Olivier Mir & Jean-Charles Soria

Authors
  1. Dana M. Hartl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Charles Ferté
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yohann Loriot
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Gomez Roca
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Rastislav Bahleda
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Cristian Moldovan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Olivier Mir
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jean-Charles Soria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dana M. Hartl.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hartl, D.M., Ferté, C., Loriot, Y. et al. Dysphonia induced by vascular endothelium growth factor/vascular endothelium growth factor receptor inhibitors. Invest New Drugs 28, 884–886 (2010). https://doi.org/10.1007/s10637-009-9314-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10637-009-9314-9

Keywords

Search

Navigation